Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 10.97
+0.27 (2.52%)
Sep 1, 2026, 3:04 PM CST
SHE:301060 Revenue
Shanghai Labway Clinical Laboratory had revenue of 304.48M CNY in the quarter ending June 30, 2026, a decrease of -25.46%. This brings the company's revenue in the last twelve months to 1.28B, down -20.64% year-over-year. In the year 2025, Shanghai Labway Clinical Laboratory had annual revenue of 1.45B, down -16.88%.
Revenue (ttm)
1.28B
Revenue Growth
-20.64%
P/S Ratio
3.33
Revenue / Employee
1.03M
Employees
1,245
Market Cap
4.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.45B | -294.15M | -16.88% |
| Dec 31, 2024 | 1.74B | 67.81M | 4.05% |
| Dec 31, 2023 | 1.67B | -2.52B | -60.13% |
| Jan 1, 2023 | 4.20B | 2.42B | 136.14% |
| Jan 1, 2022 | 1.78B | 540.14M | 43.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.72B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.63B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.18B |
| Berry Genomics Co.,Ltd | 929.15M |
| Thalys Medical Technology Group | 836.23M |
| SMO ClinPlus CO.,LTD. | 824.77M |